PedAM
Pediatric Disease Annotations & Medicines
| Disease | thromboembolism |
| Phenotype | C0398623|hypercoagulability |
| Sentences | 5 |
| PubMedID- 25081831 | The remaining 22 cases (40%) were attributed to malignancy-related hypercoagulability and the presence of additional venous thromboembolism risk factors, such as previous surgery, immobilisation, or chemotherapy. |
| PubMedID- 21631645 | Background and purpose: although hypercoagulability-induced thromboembolism is generally accepted as cause of cerebral ischaemia in thalassemic patients, cardiogenic embolism has been recently suggested as another possible stroke etiology. |
| PubMedID- 24997666 | Thromboelastography is a whole blood-based coagulation assay that can be used to investigate hypocoagulability and hypercoagulability, as seen with thromboembolic diseases and disseminated intravascular coagulation. |
| PubMedID- 23198154 | Although surgery, chemotherapy, central venous catheters, and systemic hypercoagulability were associated with venous thromboembolism (vte) in cancer, previous reports on the association of fvl and/or prothrombin 20210a with cancer-associated vte are few and present conflicting results [14–18]. |
| PubMedID- 22343687 | However, complications, including hypercoagulability, increased risk of venous thromboembolism and the exertional exercise syndrome with rhabdomyolysis and sudden death, have been described. |
Page: 1